查看购物车
  • Traditional Chinese
  • English
2021-2031 年亚太地区类器官服务市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1843397

2021-2031 年亚太地区类器官服务市场报告（范围、细分、动态和竞争分析）

Asia Pacific Organoids Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 136 Pages | 订单完成后即时交付

价格

亚太地区类器官服务市场预计将大幅成长，到 2031 年将达到约 23.271 亿美元，高于 2024 年的 5.1583 亿美元，在 2024 年至 2031 年的预测期内，年复合成长率(CAGR) 将达到 24.0%。

执行摘要和市场分析

市场分为几个区域，包括澳洲、中国、印度、日本、韩国和亚太其他地区。该地区的快速增长受到多种因素的推动，包括类器官的普及率不断提高、政府为提高公众对人体类器官的认识而采取的倡议、对先进类器官产品开发和商业化的支持性监管框架，以及类器官研究资金的增加。

市场区隔分析

亚太地区类器官服务市场可按类型、应用和来源细分：

  • 依类型：市场包括肠、肝、胃、胰臟、肺、脑、肾等部分。预计到2024年，肠道部分将占据市场份额的主导地位。
  • 依应用分类：应用分为发育生物学疾病、传染病病理学、再生医学、药物毒性和疗效测试、药物发现和个人化医疗等。预计发育生物学疾病领域将在2024年占据最大的市场份额。
  • 依来源：市场分为多能干细胞和器官特异性成体干细胞，预计多能干细胞部分将在 2024 年占据市场份额的首位。

市场展望

医疗保健产业的进步推动了全球对类器官的需求成长，促进了新产品的开发、收购、合作和产品发布。近期市场值得关注的发展包括：

  • 2024 年 6 月：Molecular Devices, LLC 在英国卡迪夫开设了一家新工厂，旨在利用创新的生物製程技术大规模生产患者来源的类器官 (PDO)。
  • 2024 年 5 月：InSphero 与 Genome Biologics 建立合作关係，将 3D 心臟类器官平台商业化，增强心臟病研究能力。
  • 2024 年 1 月：HUB Organoids 推出 IntegriGut Screen 服务，利用 IBD 患者来源的类器官单层来支持新型 IBD 疗法的开发。
  • 2023 年 7 月：Molecular Devices 扩展了其客製化类器官线服务，以用于高通量应用。
  • 2023 年 2 月：Molecular Devices 和 HUB Organoids 之间的策略合作旨在推进 3D 生物技术以降低药物损耗率。
  • 2022 年 12 月：Molecular Devices 收购 Cellesce Ltd.，以增强用于药物筛选的 PDO 生产能力。
  • 2021 年 8 月：STEMCELL Technologies 与 HUB 合作，提供用于临床前测试的组织来源的类器官。
  • 2020 年 5 月：CELLINK 与阿斯特捷利康合作开发 3D 生物列印肝类器官用于药物研发。
  • 2020 年 2 月：InnoSer 和 OrganoTherapeutics 宣布合作将中脑类器官商业化用于帕金森氏症研究。

这些发展显示市场前景活跃，类器官服务具有巨大的成长机会。

国家洞察

亚太类器官服务市场涵盖澳洲、中国、印度、日本、韩国等主要国家。预计到2024年，中国将占据最大的市场份额，这得益于人们对个人化医疗日益增长的兴趣，这推动了类器官的研究和开发。中国值得关注的措施包括HUB与青岛华大基因合作，以加强个人化医疗，以及推出搭载人脑类器官的机器人，这些都展示了类器官技术的进步。

公司简介

亚太类器官服务市场的关键参与者包括 CUSABIO TECHNOLOGY LLC、Cyprio、Eurofins Scientific SE、HUB Organoids BV、InnoSer、InSphero、LABTOO、Molecular Devices, LLC、Oncodesign Services 和 Sino Biological Inc. 这些公司正在扩大产品和市场扩张产品，以增强其市场和市场扩张产品。

目录

第一章：简介

第二章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：亚太地区类器官服务市场格局

  • PEST分析

第五章：亚太类器官服务市场－主要市场动态

  • 亚太地区类器官服务市场－关键市场动态
  • 市场驱动因素
    • 创新药物筛选服务需求不断成长
    • 个人化药物的普及度激增
  • 市场限制
    • 缺乏熟练的专业人员
  • 市场机会
    • 增加关键发展
  • 未来趋势
    • 人工智慧的融合
  • 驱动因素和限制因素的影响：

第六章：亚太地区类器官服务市场 - 分析

  • 2021-2031年亚太地区类器官服务市场收入
  • 亚太地区类器官服务市场预测分析

第七章：亚太地区类器官服务市场分析－依类型

  • 肠
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第八章：亚太地区类器官服务市场分析－依应用

  • 发育生物学疾病
  • 传染病病理学
  • 再生医学
  • 药物毒性和疗效测试
  • 药物研发与个人化医疗
  • 其他的

第九章：亚太地区类器官服务市场分析－依来源

  • 多能干细胞
  • 器官特异性成体干细胞

第 10 章：亚太地区类器官服务市场 - 国家分析

  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 亚太其他地区

第 11 章：产业格局

  • 概述
  • 类器官服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十二章：公司简介

  • Sino Biological Inc.
  • Eurofins Scientific SE
  • Molecular Devices, LLC.
  • InSphero
  • Cyprio
  • InnoSer
  • LABTOO
  • CUSABIO TECHNOLOGY LLC
  • Oncodesign Services
  • HUB Organoids B.V. (Hubrecht Organoid Technology)

第 13 章：附录

Product Code: BMIRE00032025

The Asia Pacific organoids services market is projected to grow significantly, reaching approximately US$ 2,327.10 million by 2031, up from US$ 515.83 million in 2024, reflecting a robust compound annual growth rate (CAGR) of 24.0% during the forecast period from 2024 to 2031.

Executive Summary and Market Analysis

The market is divided into several regions, including Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The rapid growth in this region is driven by several factors, including the increasing adoption of organoids, government initiatives to promote awareness of human organoids, supportive regulatory frameworks for the development and commercialization of advanced organoid products, and a rise in funding for organoid research.

Market Segmentation Analysis

The Asia Pacific organoids services market can be segmented by type, application, and source:

  • By Type: The market includes segments such as intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2024, the intestine segment is expected to dominate the market share.
  • By Application: The applications are categorized into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is anticipated to hold the largest market share in 2024.
  • By Source: The market is divided into pluripotent stem cells and organ-specific adult stem cells, with the pluripotent stem cells segment expected to lead in market share in 2024.

Market Outlook

The healthcare sector's advancements have led to increased demand for organoids globally, fostering new product developments, acquisitions, partnerships, and product launches. Recent notable developments in the market include:

  • June 2024: Molecular Devices, LLC opened a new facility in Cardiff, UK, designed for large-scale production of patient-derived organoids (PDOs) using innovative bioprocess technology.
  • May 2024: InSphero entered a partnership with Genome Biologics to commercialize a 3D Cardiac Organoid Platform, enhancing heart disease research capabilities.
  • January 2024: HUB Organoids launched IntegriGut Screen services, utilizing IBD patient-derived organoid monolayers to support the development of new IBD therapies.
  • July 2023: Molecular Devices expanded its custom organoid line service for high-throughput applications.
  • February 2023: A strategic collaboration between Molecular Devices and HUB Organoids aimed to advance 3D biology technologies to reduce drug attrition rates.
  • December 2022: Molecular Devices acquired Cellesce Ltd. to enhance PDO production capabilities for drug screening.
  • August 2021: STEMCELL Technologies partnered with HUB to provide tissue-derived organoids for preclinical testing.
  • May 2020: CELLINK collaborated with AstraZeneca to develop 3D bioprinted liver organoids for drug discovery.
  • February 2020: InnoSer and OrganoTherapeutics announced a collaboration to commercialize midbrain organoids for Parkinson's disease research.

These developments indicate a vibrant market landscape with numerous opportunities for growth in organoid services.

Country Insights

The Asia Pacific Organoids Services Market includes key countries such as Australia, China, India, Japan, South Korea, and others. China is expected to hold the largest market share in 2024, driven by the growing interest in personalized medicine, which fuels organoid research and development. Notable initiatives in China include a partnership between HUB and BGI-Qingdao to enhance personalized care and the introduction of a robot with a human brain organoid, showcasing advancements in organoid technology.

Company Profiles

Key players in the Asia Pacific organoids services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V., InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Organoids Services Market Landscape

  • 4.1 PEST Analysis

5. Asia Pacific Organoids Services Market - Key Market Dynamics

  • 5.1 Asia Pacific Organoids Services Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Demand for Innovative Drug Screening Services
    • 5.2.2 Surge in Popularity of Personalized Drugs
  • 5.3 Market Restraints
    • 5.3.1 Dearth of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Key Developments
  • 5.5 Future Trends
    • 5.5.1 Integration of Artificial Intelligence
  • 5.6 Impact of Drivers and Restraints:

6. Asia Pacific Organoids Services Market - Analysis

  • 6.1 Asia Pacific Organoids Services Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Organoids Services Market Forecast Analysis

7. Asia Pacific Organoids Services Market Analysis - by Type

  • 7.1 Intestine
    • 7.1.1 Overview
    • 7.1.2 Intestine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview
    • 7.2.2 Liver: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Pancreas
    • 7.4.1 Overview
    • 7.4.2 Pancreas: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Lung
    • 7.5.1 Overview
    • 7.5.2 Lung: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Brain
    • 7.6.1 Overview
    • 7.6.2 Brain: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Kidney
    • 7.7.1 Overview
    • 7.7.2 Kidney: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Organoids Services Market Analysis - by Application

  • 8.1 Developmental Biology Disease
    • 8.1.1 Overview
    • 8.1.2 Developmental Biology Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease
    • 8.2.1 Overview
    • 8.2.2 Pathology of Infectious Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine
    • 8.5.1 Overview
    • 8.5.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Organoids Services Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview
    • 9.1.2 Pluripotent Stem Cells: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Organ Specific Adult Stem Cell
    • 9.2.1 Overview
    • 9.2.2 Organ Specific Adult Stem Cell: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Organoids Services Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Asia Pacific Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 Japan: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.2.2 Japan: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.2.3 Japan: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.3 China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 China: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.3.2 China: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.3.3 China: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.4 India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 India: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.4.2 India: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.4.3 India: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.5 South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 South Korea: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.5.2 South Korea: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.5.3 South Korea: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.6 Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 Australia: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.6.2 Australia: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.6.3 Australia: Asia Pacific Organoids Services Market Share - by Source
      • 10.1.1.7 Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Type
        • 10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Application
        • 10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Source

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organoids Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Sino Biological Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Eurofins Scientific SE
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Molecular Devices, LLC.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 InSphero
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Cyprio
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 InnoSer
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 LABTOO
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 CUSABIO TECHNOLOGY LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Oncodesign Services
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Organoids Services Market Segmentation
  • Table 2. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 8. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 9. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 10. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 11. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 12. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 13. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 14. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 15. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 16. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 20. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 21. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 22. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 23. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 24. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 25. Recent Organic Growth Strategies in Organoids Services Market
  • Table 26. Recent Inorganic Growth Strategies in the Organoids Services Market
  • Table 27. Glossary of Terms, Organoids Services Market

List Of Figures

  • Figure 1. Asia Pacific Organoids Services Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Organoids Services Market Revenue (US$ Million), 2021-2031
  • Figure 5. Asia Pacific Organoids Services Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Liver: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Stomach: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Pancreas: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Lung: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Brain: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Kidney: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Asia Pacific Organoids Services Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Asia Pacific Organoids Services Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Organ Specific Adult Stem Cell: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Asia Pacific Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 25. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 28. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 29. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 30. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 31. Growth Strategies in Organoids Services Market